Xie Bing-fen, Feng Gong-kan, Zhu Xiao-feng, Su Xiu-rong, Liu Zong-chao, Yang Ren-zhou, Wei Xiao-yi
Cancer Institute, Cancer Center, Sun Yet-sen University, Guangzhou 510060, P. R. China.
Ai Zheng. 2002 Apr;21(4):379-82.
BACKGROUND & OBJECTIVE: The authors' previous studies have demonstrated that anuoning bullatacin and squamocin have anticancer activity in vitro. Squamocin could induce apoptosis of HL-60 cells. The purpose of this paper was to investigate cytotoxicity and antitumor effect of anuoning.
MTT assay was used to examine the growth inhibition of anuoning on human colon carcinoma cell line (HT-29), human nasopharyngeal carcinoma cell line (SUNE1, CNE2), human liver carcinoma (bel-7402), human breast adenocarcinoma cell line (MCF-7) and human lung adenocarcinoma cell line (GLC-82). The models of mice S-180 sarcoma and HepS were used for in vivo antitumor test.
The IC50 of anuoning on CNE2, bel-7402, HT-29, SUNE1 cell were 0.044, 0.068, 0.446, and 1.617 micrograms/ml, respectively. The IC50 of anuoning on MCF-7 cell and GLC-82 cell were 1.857 and 3.481 micrograms/ml, respectively. Under the doses of 15, 30, and 60 micrograms/kg, i.p., qd x 10 d, the average tumor inhibitory rates of anuoning to mice tumor HepS were 36.9%, 51.8%, and 57.9%, respectively (P < 0.05). Under the same concentration, the average tumor inhibitory rates of anuoning on mice S-180 sarcoma were 43.0%, 52.1%, and 61.0%, respectively (P < 0.05).
The results indicate that the anuoning possess cell growth inhibition activity to various human tumor cells in vitro and antitumor effect in vivo.
作者之前的研究表明,阿诺宁、布拉他辛和南美番荔枝素在体外具有抗癌活性。南美番荔枝素可诱导HL-60细胞凋亡。本文旨在研究阿诺宁的细胞毒性和抗肿瘤作用。
采用MTT法检测阿诺宁对人结肠癌细胞系(HT-29)、人鼻咽癌细胞系(SUNE1、CNE2)、人肝癌细胞(bel-7402)、人乳腺腺癌细胞系(MCF-7)和人肺腺癌细胞系(GLC-82)的生长抑制作用。采用小鼠S-180肉瘤和HepS模型进行体内抗肿瘤试验。
阿诺宁对CNE2、bel-7402、HT-29、SUNE1细胞的IC50分别为0.044、0.068、0.446和1.617微克/毫升。阿诺宁对MCF-7细胞和GLC-82细胞的IC50分别为1.857和3.481微克/毫升。腹腔注射阿诺宁15、30和60微克/千克,每日1次,连续10天,其对小鼠HepS肿瘤的平均抑瘤率分别为36.9%、51.8%和57.9%(P<0.05)。在相同浓度下,阿诺宁对小鼠S-180肉瘤的平均抑瘤率分别为43.0%、52.1%和61.0%(P<0.05)。
结果表明,阿诺宁在体外对多种人肿瘤细胞具有细胞生长抑制活性,在体内具有抗肿瘤作用。